- Report
- May 2025
- 192 Pages
Global
From €3183EUR$3,545USD£2,711GBP
€3537EUR$3,939USD£3,012GBP
- Report
- November 2024
- 323 Pages
Global
From €4489EUR$5,000USD£3,823GBP
- Report
- June 2025
- 89 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- August 2024
- 148 Pages
Global
From €2693EUR$2,999USD£2,293GBP
- Report
- January 2025
- 190 Pages
Global
From €2245EUR$2,500USD£1,912GBP
- Report
- May 2025
- 188 Pages
Global
From €3434EUR$3,825USD£2,925GBP
€4040EUR$4,500USD£3,441GBP
- Report
- July 2024
- 120 Pages
Global
From €4265EUR$4,750USD£3,632GBP
- Report
- February 2025
- 200 Pages
Global
From €4031EUR$4,490USD£3,433GBP
- Report
- December 2024
- 552 Pages
Global
From €4309EUR$4,799USD£3,669GBP
- Report
- May 2025
- 186 Pages
Global
From €3183EUR$3,545USD£2,711GBP
€3537EUR$3,939USD£3,012GBP
- Report
- May 2025
- 185 Pages
Global
From €3183EUR$3,545USD£2,711GBP
€3537EUR$3,939USD£3,012GBP
- Report
- May 2025
- 189 Pages
Global
From €3183EUR$3,545USD£2,711GBP
€3537EUR$3,939USD£3,012GBP
- Report
- May 2025
- 175 Pages
Global
From €4031EUR$4,490USD£3,433GBP
- Report
- June 2025
- 89 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- February 2024
- 80 Pages
India
From €5342EUR$5,950USD£4,549GBP
- Report
- April 2022
- 275 Pages
Global
From €5342EUR$5,950USD£4,549GBP
- Report
- April 2024
- 80 Pages
United States
From €3547EUR$3,950USD£3,020GBP
- Report
- November 2022
- 117 Pages
Global
From €4444EUR$4,950USD£3,785GBP
- Report
- October 2023
- 117 Pages
Global
From €4040EUR$4,500USD£3,441GBP
- Report
- November 2023
- 117 Pages
Global
From €4040EUR$4,500USD£3,441GBP

The Preclinical CRO market is a subset of the Drug Discovery industry, focusing on the preclinical stages of drug development. Preclinical CROs provide services such as drug safety testing, pharmacology studies, and toxicology studies. These services are used to assess the safety and efficacy of potential drugs before they are tested in humans. Preclinical CROs also provide services such as drug metabolism and pharmacokinetics, which are used to understand how a drug is absorbed, distributed, metabolized, and eliminated in the body.
Preclinical CROs are an important part of the drug discovery process, as they provide the data needed to move a drug candidate forward in the development process. Preclinical CROs are also used to reduce the cost and time associated with drug development, as they can provide the data needed to make decisions quickly and efficiently.
Some companies in the Preclinical CRO market include Charles River Laboratories, WuXi AppTec, Covance, PRA Health Sciences, and Envigo. Show Less Read more